Kim N. Chi
600 West 10th Avenue, V5Z 4E6
Vancouver, BC, Canada
Vancouver, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 302 publications
Outcomes of a Canadian real-world cohort of metastatic castration-sensitive prostate cancer patients stratified by early PSA nadir.
Journal: Future oncology (London, England)
Published: June 19, 2026
Cell-free DNA in prostate cancer and treatment selection.
Journal: Expert review of anticancer therapy
Published: June 10, 2026
Saruparib in combination with androgen receptor pathway inhibitors in metastatic hormone-sensitive prostate cancer: EvoPAR-Prostate01.
Journal: Future oncology (London, England)
Published: April 14, 2026
Genetic testing practices among specialist physicians who treat prostate cancer: Updated survey of Canadian practitioners.
Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada
Published: April 06, 2026
Genetic testing practices among specialist physicians who treat prostate cancer Updated survey of Canadian practitioners.
Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada
Published: April 06, 2026
Eight-year outcomes of testosterone suppression plus enzalutamide or a non-steroidal anti-androgen for metastatic, hormone-sensitive prostate cancer (ENZAMET; ANZUP 1304).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 01, 2026
Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 26, 2026
Phase Ib Trial of Bavdegalutamide (ARV-110) in Combination with Abiraterone for Metastatic Prostate Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 27, 2026
Germline CDK12 variants in aggressive prostate cancer.
Journal: Cancer discovery
Published: January 14, 2026
Niraparib With Abiraterone Acetate Plus Prednisone as First-Line Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer With Homologous Recombination Repair Gene Alterations: Final Analysis of the Asian Subgroup From the MAGNITUDE Study.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: December 18, 2025
Metformin modifies hormone changes associated with androgen deprivation therapy for prostate cancer.
Metformin modifies hormone changes associated with androgen deprivation therapy for prostate cancer.
Journal: Endocrine oncology (Bristol, England)
Published: December 09, 2025
Radiographic Progression Without Prostate-specific Antigen Progression in Metastatic Hormone-sensitive Prostate Cancer: A Retrospective Analysis of the ENZAMET Trial (ANZUP 1304).
Journal: European urology oncology
Published: November 10, 2025
Last Updated: 09/26/2026